Skip to main content

Advertisement

Log in

Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

We identified 11 Lomentospora prolificans isolates recovered from Mexican patients using phenotypic and molecular characteristics. The identification of isolates was assessed by internal transcribed spacer (ITS rDNA) sequencing. In vitro susceptibility to amphotericin B, fluconazole, voriconazole, posaconazole, caspofungin, anidulafungin and micafungin was determined according to Clinical and Laboratory Standards Institute (CLSI) procedures. Three isolates (07-2239, 11-2242 and 04-2673) were used to induce systemic infection in immunocompetent ICR mice. Survival and tissue burden studies were used as markers of pathogenicity. All of the strains were resistant to every antifungal tested with MIC’s for AmB (8–>8 µg/ml), VRC (16–>16 µg/ml), PSC (16–>16 µg/ml), FLC (64–>64 µg/ml) and echinocandins with MICs ≥8 µg/ml. One hundred, ninety and sixty percent of the infected mice with the strains 07-2239, 11-2242 and 04-2673 died during the study, respectively. Regarding tissue burden, the highest fungal load of the infected mice was detected in brain followed by spleen and kidney, regardless of the strain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lackner M, de Hoog GS. Proposed nomenclature for Pseudallescheria, Scedosporium and related genera. Fungal Divers. 2014;67:1–10.

    Article  Google Scholar 

  2. De Hoog GS, Guarro J, Gene J, Figueras MJ. Hyphomycetes. Genus: Scedosporium. In: Atlas of clinical fungi, 2nd ed. Utrecht, Centraalbureau voor Schimmelcultures, 2000:899–901.

  3. Gosbell IB, Morris ML, Gallo JH, Weeks KS, Neville SA, Rogers AH. Andrews rh, Ellis HD. Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: four cases and review. Clin Microbiol Infect. 1999;5:672–86.

    Article  Google Scholar 

  4. Panackal AA, Marr KA. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med. 2004;25(2):171–81.

    Article  PubMed  Google Scholar 

  5. Rodriguez-Tudela JL, Berenguer J, Guarro J, Kantarcioglu AS, Horre R, de Hoog GS, Cuenca-Estrella M. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47(4):359–70.

    Article  PubMed  Google Scholar 

  6. Johnson LS, Shields RK, Clancy CJ. Epidemiology, clinical manifestations, and outcomes of Scedosporium infections among solid organ transplant recipients. Transpl Infect Dis. 2014;16:578–87.

    Article  CAS  PubMed  Google Scholar 

  7. Guarro J, Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis. 1995;14:741–54.

    Article  CAS  PubMed  Google Scholar 

  8. Guarro J, Gams W, Pujol I, Gene J. Acremonium species: new emerging fungal opportunists. In vitro antifungal susceptibilities and review. Clin Infect Dis. 1997;25:1222–9.

    Article  CAS  PubMed  Google Scholar 

  9. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Ortoneda M, Capilla J, Pujol I, Pastor FJ, Mayayo E, Fernández-Ballart J, Guarro J. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother. 2002;49(3):525–9.

    Article  CAS  PubMed  Google Scholar 

  11. Capilla J, Yustes C, Mayayo E, Fernández B, Ortoneda M, Pastor FJ, Guarro J. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother. 2003;47(6):1948–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lackner M, de Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, Meis JF. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 2012;56(5):2635–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol. 2009;47(4):422–32.

    Article  CAS  PubMed  Google Scholar 

  14. Tortorano AM, Richardson M, Roilides E, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect. 2014;Suppl 3:27–46.

    Article  Google Scholar 

  15. Yarrow D. Methods for the isolation, maintenance, and identification of yeasts. In: Kurtzman CP, Fell JW, editors. The yeasts: a taxonomic study. 4th ed. Amsterdam: Elsevier; 1998.

    Google Scholar 

  16. Espinel-Ingroff A, Goldson PR, McGinnis MR, Kerkering TM. Evaluation of proteolytic activity to differentiate some dematiaceous fungi. J Clin Microbiol. 1988;26:301–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Chakrabarti A, Nayak N, Talwar P. In vitro proteinase production by Candida species. Mycopathologia. 1991;114:163–8.

    Article  CAS  PubMed  Google Scholar 

  18. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982;20:7–14.

    Article  CAS  PubMed  Google Scholar 

  19. Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001;39(8):2971–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed. CLSI M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA, 2008.

  21. González GM, Rojas OC, Bocanegra-García V, González JG, Garza-González E. Molecular diversity of Cladophialophora carrionii in patients with chromoblastomycosis in Venezuela. Med Mycol. 2013;51(2):170–7.

    Article  PubMed  Google Scholar 

  22. Irinyi L, Serena C, García-Hermoso D, et al. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database-the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med Mycol. 2015;53(4):313–37.

    Article  CAS  PubMed  Google Scholar 

  23. Ortoneda M, Pastor FJ, Mayayo E, Guarro J. Comparison of the virulence of Scedosporium prolificans strains from different origins in a murine model. J Med Microbiol. 2002;51(11):924–8.

    Article  CAS  PubMed  Google Scholar 

  24. Nweze EI, Okafor JI. Comparative virulence of Scedosporium species in animal models. Braz J Infect Dis. 2010;14(3):271–6.

    Article  CAS  PubMed  Google Scholar 

  25. Harun A, Serena C, Gilgado F, Chen SC, Meyer W. Scedosporium aurantiacum is as virulent as S. prolificans, and shows strain-specific virulence differences, in a mouse model. Med Mycol. 2010;48(1):S45–51.

    Article  PubMed  Google Scholar 

  26. Tintelnot K, Just-Nübling G, Horré R, Graf B, Sobottka I, Seibold M, Haas A, Kaben U, De Hoog GS. A Review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol. 2009;47(4):351–8.

    Article  CAS  PubMed  Google Scholar 

  27. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989–2006. Clin Inf Dis. 2006;43:1580–684.

    Article  Google Scholar 

  28. Del Palacio A, Garau M, Amor E, Martinez-Alonso I, Calvo T, Carrillo-Muñoz A, Guarro J. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses. 2001;44:321–5.

    Article  PubMed  Google Scholar 

  29. Vagefi MR, Kim ET, Alvarado RG, Duncan JL, Howes EL, Crawford JB. Bilateral endogenous Scedosporium prolificans endophthalmitis after lung transplantation. Am J Ophthalmol. 2005;139:370–3.

    Article  PubMed  Google Scholar 

  30. Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis. 2003;22:111–3.

    CAS  PubMed  Google Scholar 

  31. Wedde M, Müller D, Tintelnot K, de Hoog GS, Stahl U. PCR based identification of clinically relevant Pseudallescheria/Scedosporium strains. Med Mycol. 1998;36:61–7.

    Article  CAS  PubMed  Google Scholar 

  32. Lennon PA, Cooper CR, Salkin IF, Lee SB. Ribosomal DNA internal transcribed spacer analysis supports synonym of Scedosporium inflatum and Lomentospora prolificans. J Clin Microbiol. 1994;32:2413–6.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was made possible through support from Conacyt-INFRA-2015-01 (code 251142).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gloria M. González.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest. The authors alone are responsible for the content and the writing of the paper.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elizondo-Zertuche, M., Montoya, A.M., Robledo-Leal, E. et al. Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients. Mycopathologia 182, 681–689 (2017). https://doi.org/10.1007/s11046-017-0137-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-017-0137-5

Keywords

Navigation